Skip to content

Nasal high-flow therapy during double lumen endotracheal intubation in patients undergoing lung surgery: a randomized clinical trial

Nasal high-flow therapy during double lumen endotracheal intubation in patients undergoing lung surgery: a randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064596
Enrollment
Unknown
Registered
2022-10-12
Start date
2022-11-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung disease

Interventions

Experimental group:High flow oxygenation during intubation
Control group:Blank control

Sponsors

Shenzhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-60 years old; 2. DLT intubation is required for elective VATS assisted lung surgery; 3. Agree to participate in this study.

Exclusion criteria

Exclusion criteria: 1. ASA grade > IV; 2. Severe nasal obstruction; 3. Difficult intubation or mask ventilation is expected; 4. Morbid obesity (BMI > 35 kg/m2); 5. Abnormal airway anatomy; 6. Abnormal coagulation function; 7. Emergency surgery is planned; 8. High risk of reflux aspiration; 9. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
lowest oxygen saturation;

Secondary

MeasureTime frame
The lowest incidence of SpO2 < 90%;The lowest incidence of SpO2 < 95%;Intubation time;End expiratory carbon dioxide partial pressure after intubation;End expiratory oxygen concentration after intubation;Incidence of difficult airway;Incidence of malposition of bronchial intubation;Related complications during intubation;Operator satisfaction with intubation;Postoperative airway related complications;Incidence of nausea and vomiting;Incidence of low blood oxygen saturation (SpO2 < 90%) in PACU;Patient satisfaction with anesthesia;Postoperative hospital stay;

Countries

China

Contacts

Public ContactNanbo Luo

Shenzhen Second People's Hospital

316916645@qq.com+86 15112389303

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026